AYMHY
LIVE

Serial Number

99328385

Owner

Rezolute, Inc.

Attorney

Olivia Maria Baratta

Filing Date

Aug 8, 2025

Add to watchlist:

No watchlists yet
View on USPTO

AYMHY Trademark

Serial Number: 99328385

AYMHY is a trademark filed by Rezolute, Inc. on August 8, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Rezolute, Inc. (7 trademarks)

201 Redwood Shores Pkwy, Suite 315
Redwood City, CA 94065

Entity Type: 03

Trademark Details

Filing Date

August 8, 2025

Registration Date

Not Registered

Goods & Services

Pharmaceutical preparations for the treatment of metabolic diseases and orphan diseases, namely, overactivation of insulin receptor by insulin or insulin-like substances, including congenital hyperinsulinism, tumor hyperinsulinism caused by insulinomas and non-islet cell tumors (IGF-2 mediated), transient hypoglycemia (e.g., perinatal stress or related causes), post-bariatric hyperinsulinism (PBHI), post-gastrectomy hyperinsulinism, nesidioblastosis, activating insulin receptor autoantibodies, insulin autoimmune syndrome (IAS), Hirata's disease, monogenic diabetes

Pharmaceutical research and development services

Filing History

TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 10, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 10, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 10, 2026 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Feb 3, 2026 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Feb 3, 2026 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 23, 2025 GNRN
NON-FINAL ACTION E-MAILED
Dec 23, 2025 GNRT
NON-FINAL ACTION WRITTEN
Dec 23, 2025 CNRT
ASSIGNED TO EXAMINER
Dec 23, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 8, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 8, 2025 NWOS
NEW APPLICATION ENTERED
Aug 8, 2025 NWAP